Following positive clinical findings , retatrutide, a new peptide therapy for addressing adult-onset hyperglycemia , has received regulatory approval from UK’s Healthcare and Healthcare Agency (MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/